Health Care: Drugs

Coherus BioSciences Inc (CHRS: NASDAQ)

$13.65 n/a | n/a%
07/21/17 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 13.65
52 Week High 31.98
52 Week Low 12.85
Avg. Daily Vol. (Mil) 0.84
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 700.08
Shares Out (Mil) 51.29
Float (Mil) 31.39
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.70
Current Ratio 4.40
LT Debt/ Equity 1.29
Total Debt / Equity 1.31
Valuation Ratios
Price Earnings n.a.
Price/Sales 3.94
Price/Book 8.96
Price/Cash Flow -5.20
Per Share Data
Earnings -3.38
Sales 3.47
Book Value 1.52
Cash Flow -2.61
Business Summary
Coherus BioSciences Inc is a biotechnology company that develops biosimilar therapeutics. The company seeks to ensure successful drug development and manufacturing under very aggressive timelines.
General Information
333 Twin Dolphin Drive
Suite 600
Redwood City, CA 94065
Industry : Drugs
Sector: Health Care
Employees: 169
CEO: Dennis M. Lanfear
Short Interest
Current Month (Mil) 6.00
Previous Month (Mil) 5.29
Short Interest Ratio (Days) 5.10
Management Effectiveness
Return on Equity n.a.
Return on Assets -60.30
Return on Investments -76.70
Gross Margin n.a.
EBIT Margin -73.60
Profit Margin -77.00

Portfolios with CHRS

Latest CHRS Headlines from TheStreet

More Financial News for CHRS

Press Releases for CHRS

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter